EVEROLIMUS for Prostate cancer: Side Effects & Safety Data
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
There are 42 adverse event reports in the FDA FAERS database where EVEROLIMUS was used for Prostate cancer.
Most Reported Side Effects for EVEROLIMUS
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Death | 5,090 | 12.8% | 5,065 | 421 |
| Malignant neoplasm progression | 3,789 | 9.6% | 1,120 | 1,076 |
| Diarrhoea | 3,061 | 7.7% | 357 | 1,273 |
| Fatigue | 2,946 | 7.4% | 348 | 975 |
| Stomatitis | 2,692 | 6.8% | 203 | 621 |
| Nausea | 2,079 | 5.2% | 222 | 880 |
| Dyspnoea | 1,925 | 4.9% | 424 | 1,072 |
| Drug ineffective | 1,837 | 4.6% | 251 | 398 |
| Pyrexia | 1,664 | 4.2% | 242 | 1,072 |
| Decreased appetite | 1,633 | 4.1% | 223 | 682 |
| Rash | 1,603 | 4.0% | 127 | 323 |
| Vomiting | 1,575 | 4.0% | 230 | 862 |
| Malaise | 1,545 | 3.9% | 230 | 674 |
| Weight decreased | 1,536 | 3.9% | 230 | 635 |
| Cough | 1,480 | 3.7% | 199 | 657 |
Other Indications for EVEROLIMUS
Product used for unknown indication (9,230)
Breast cancer (4,442)
Breast cancer metastatic (2,751)
Renal cancer (1,989)
Immunosuppressant drug therapy (1,847)
Renal transplant (1,604)
Renal cell carcinoma (1,573)
Neuroendocrine tumour (1,284)
Prophylaxis against transplant rejection (862)
Angiomyolipoma (794)
Other Drugs Used for Prostate cancer
LEUPROLIDE (45,399)
ENZALUTAMIDE (25,954)
RELUGOLIX (18,752)
ABIRATERONE (12,209)
APALUTAMIDE (3,286)
GOSERELIN (2,080)
DEGARELIX (2,035)
BICALUTAMIDE (1,832)
SIPULEUCEL-T (1,720)
DENOSUMAB (1,627)